Unheard of to have a trial with 19 participants show statistical signifigance easily beating .05 standard.....
Big pharma runs trials with 5000 patients to show an overall benefit of life extension for a month that has huge side effects. And they call that a great new drug...Pfff to the drugs that dont cure,have horendous side effects and effectivness decreases quickly.
Ann: FDA Grants Orphan Drug Designation for Revascor, page-273
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.080(8.42%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | $1.03 | 95.0¢ | $1.549M | 1.570M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 7645 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 70330 | 8 |
View Market Depth
| Last trade - 10.26am 30/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |